annual ROE:
54.39%+82.98%(+290.24%)Summary
- As of today (July 1, 2025), PTGX annual return on equity is 54.39%, with the most recent change of +82.98% (+290.24%) on December 31, 2024.
- During the last 3 years, PTGX annual ROE has risen by +97.71% (+225.55%).
- PTGX annual ROE is now at all-time high.
Performance
PTGX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
9.37%-42.64%(-81.98%)Summary
- As of today (July 1, 2025), PTGX quarterly return on equity is 9.37%, with the most recent change of -42.64% (-81.98%) on March 1, 2025.
- Over the past year, PTGX quarterly ROE has dropped by -38.04% (-80.24%).
- PTGX quarterly ROE is now -81.98% below its all-time high of 52.01%, reached on December 31, 2024.
Performance
PTGX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PTGX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +290.2% | -80.2% |
| 3 y3 years | +225.6% | +123.7% |
| 5 y5 years | +167.8% | +109.5% |
PTGX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +210.1% | -82.0% | +116.7% |
| 5 y | 5-year | at high | +167.8% | -82.0% | +112.5% |
| alltime | all time | at high | +135.1% | -82.0% | +106.0% |
PTGX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | 9.37%(-82.0%) |
| Dec 2024 | 54.39%(-290.2%) | 52.01%(+38.4%) |
| Sep 2024 | - | 37.59%(-10.0%) |
| Jun 2024 | - | 41.76%(-11.9%) |
| Mar 2024 | - | 47.41%(-263.9%) |
| Dec 2023 | -28.59%(-42.1%) | -28.93%(-47.6%) |
| Sep 2023 | - | -55.24%(-0.6%) |
| Jun 2023 | - | -55.60%(-1.2%) |
| Mar 2023 | - | -56.29%(+17.4%) |
| Dec 2022 | -49.41%(+14.1%) | -47.93%(+6.3%) |
| Sep 2022 | - | -45.08%(+5.8%) |
| Jun 2022 | - | -42.61%(+7.7%) |
| Mar 2022 | - | -39.56%(-3.8%) |
| Dec 2021 | -43.32%(+17.7%) | -41.14%(+6.8%) |
| Sep 2021 | - | -38.52%(+16.6%) |
| Jun 2021 | - | -33.03%(-11.5%) |
| Mar 2021 | - | -37.32%(-14.3%) |
| Dec 2020 | -36.79% | -43.56%(-22.6%) |
| Sep 2020 | - | -56.31%(-24.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -74.94%(-23.7%) |
| Mar 2020 | - | -98.27%(+20.4%) |
| Dec 2019 | -80.20%(+140.2%) | -81.60%(+14.7%) |
| Sep 2019 | - | -71.14%(+14.3%) |
| Jun 2019 | - | -62.23%(+53.5%) |
| Mar 2019 | - | -40.54%(+20.7%) |
| Dec 2018 | -33.39%(-5.9%) | -33.59%(+25.4%) |
| Sep 2018 | - | -26.79%(+2.3%) |
| Jun 2018 | - | -26.20%(-24.0%) |
| Mar 2018 | - | -34.47%(-26.7%) |
| Dec 2017 | -35.50%(-16.4%) | -47.02%(-26.8%) |
| Sep 2017 | - | -64.20%(+8.6%) |
| Jun 2017 | - | -59.09%(+4.8%) |
| Mar 2017 | - | -56.40%(-12.1%) |
| Dec 2016 | -42.46%(-72.6%) | -64.14%(-21.5%) |
| Sep 2016 | - | -81.68%(-44.8%) |
| Jun 2016 | - | -147.85%(+11.2%) |
| Mar 2016 | - | -132.91%(-14.2%) |
| Dec 2015 | -154.84%(+11.3%) | -154.84% |
| Dec 2014 | -139.18% | - |
FAQ
- What is Protagonist Therapeutics annual return on equity?
- What is the all time high annual ROE for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual ROE year-on-year change?
- What is Protagonist Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly ROE year-on-year change?
What is Protagonist Therapeutics annual return on equity?
The current annual ROE of PTGX is 54.39%
What is the all time high annual ROE for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual return on equity is 54.39%
What is Protagonist Therapeutics annual ROE year-on-year change?
Over the past year, PTGX annual return on equity has changed by +82.98% (+290.24%)
What is Protagonist Therapeutics quarterly return on equity?
The current quarterly ROE of PTGX is 9.37%
What is the all time high quarterly ROE for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly return on equity is 52.01%
What is Protagonist Therapeutics quarterly ROE year-on-year change?
Over the past year, PTGX quarterly return on equity has changed by -38.04% (-80.24%)